SCHEMBL6452986

SCHEMBL6452986

Cc1ccc([C]=O)[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6789604 0.74 — —
SCHEMBL6443242 0.74 — —
SCHEMBL65952 0.69 — —
SCHEMBL11400539 0.69 — —
SCHEMBL3149038 0.69 HMBS (0.43) —
SCHEMBL8619374 0.66 — —
SCHEMBL6561706 0.66 — —
SCHEMBL8208273 0.66 HMBS (0.92) —
SCHEMBL11401624 0.62 — —
SCHEMBL2912200 0.59 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9045517-B2 Glycosylated aminocoumarins and methods of preparing and uses of same UNIVERSITY COLLEGE LONDON (GB) 2015-06-02 — — US disclosed
EP-2627661-B1 GLYCOSYLATED AMINOCOUMARINS AND METHODS OF PREPARING AND USES OF SAME UNIV LONDON (GB) 2015-03-18 — — EP disclosed
US-20130274213-A1 GLYCOSYLATED AMINOCOUMARINS AND METHODS OF PREPARING AND USES OF SAME UNIVERSITY COLLEGE LONDON (GB) 2013-10-17 — — US disclosed
EP-2627661-A1 GLYCOSYLATED AMINOCOUMARINS AND METHODS OF PREPARING AND USES OF SAME University College London (GB) 2013-08-21 — — EP disclosed
WO-2012049521-A1 GLYCOSYLATED AMINOCOUMARINS AND METHODS OF PREPARING AND USES OF SAME SCHOOL OF PHARMACY, UNIVERSITY OF LONDON (GB) 2012-04-19 — — WO disclosed
US-20050130941-A1 Methods of treating alzheimer's disease PHARMACIA & UPJOHN COMPANY LLC 2005-06-16 — — US disclosed
EP-1392315-A1 METHODS OF TREATING ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2004-03-03 — — EP disclosed
WO-2002100410-A1 METHODS OF TREATING ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-12-19 — — WO disclosed
US-5753652-A Antiretroviral hydrazine derivatives NOVARTIS CORPORATION (US) 1998-05-19 — — US disclosed
EP-0521827-B1 Pharmacological active hydrazin derivatives and process for their preparation CIBA GEIGY AG (CH) 1996-09-25 — — EP disclosed
EP-0521827-A1 Pharmacological active hydrazin derivatives and process for their preparation CIBA-GEIGY AG (CH) 1993-01-07 — — EP disclosed
EP-0032048-A1 Pyrroloylpyrrole derivatives, processes for their preparation and their use BEECHAM GROUP PLC (GB) 1981-07-15 — — EP disclosed
Send feedback